Literature DB >> 18721657

Basic infertility including polycystic ovary syndrome.

Maryse Brassard1, Youssef AinMelk, Jean-Patrice Baillargeon.   

Abstract

Infertility in women has many possible causes and must be approached systematically. The most common cause of medically treatable infertility is the polycystic ovary syndrome (PCOS). This syndrome is common in young women and is the cause of anovulatory infertility in 70% of cases. It is therefore an important condition to screen and manage in primary care medical settings. In the past 10 years, insulin sensitization with weight loss or metformin has been shown to be a safe and effective treatment for PCOS infertility that eliminates the risk of multiple pregnancy and may reduce the risk of early pregnancy loss as compared with ovulation-inductor drugs. The authors believe metformin should be considered as first-line therapy because it has the advantage to allow for normal single ovulation, for reduced early pregnancy loss, and, most importantly, lifestyle modifications and weight loss before pregnancy. Losing weight not only improves fertility but also reduces adverse pregnancy outcomes associated with obesity.

Entities:  

Mesh:

Year:  2008        PMID: 18721657     DOI: 10.1016/j.mcna.2008.04.008

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  27 in total

1.  Associations of adiponectin gene polymorphisms with polycystic ovary syndrome: a meta-analysis.

Authors:  Hongxia Jia; Lili Yu; Xuxiao Guo; Wei Gao; Zhaoshun Jiang
Journal:  Endocrine       Date:  2012-01-22       Impact factor: 3.633

2.  Hyper response to ovarian stimulation affects the follicular fluid metabolomic profile of women undergoing IVF similarly to polycystic ovary syndrome.

Authors:  Fernanda Bertuccez Cordeiro; Thaís Regiani Cataldi; Beatriz Zappellini de Souza; Raquel Cellin Rochetti; Renato Fraietta; Carlos Alberto Labate; Edson Guimarães Lo Turco
Journal:  Metabolomics       Date:  2018-03-16       Impact factor: 4.290

3.  Effect of body mass index and age on in vitro fertilization in polycystic ovary syndrome.

Authors:  Müberra Namlı Kalem; Ziya Kalem; Tamer Sarı; Can Ateş; Timur Gürgan
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-01-12

4.  Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysis.

Authors:  Shan Li; Xiamei Huang; Huizhi Zhong; Qiliu Peng; Siyuan Chen; Yantong Xie; Xue Qin; Aiping Qin
Journal:  Tumour Biol       Date:  2014-01-12

5.  Quantitative trait locus analysis of ovarian cysts derived from rete ovarii in MRL/MpJ mice.

Authors:  Shin-hyo Lee; Osamu Ichii; Saori Otsuka; Yoshiharu Hashimoto; Yasuhiro Kon
Journal:  Mamm Genome       Date:  2010-02-25       Impact factor: 2.957

Review 6.  Depression and Anxiety in Polycystic Ovary Syndrome: Etiology and Treatment.

Authors:  Laura G Cooney; Anuja Dokras
Journal:  Curr Psychiatry Rep       Date:  2017-09-20       Impact factor: 5.285

Review 7.  Adiponectin action from head to toe.

Authors:  Karine Brochu-Gaudreau; Charlotte Rehfeldt; Richard Blouin; V Bordignon; Bruce D Murphy; Marie-France Palin
Journal:  Endocrine       Date:  2009-12-01       Impact factor: 3.633

8.  The Effects of Probiotics or Synbiotics Supplementation in Women with Polycystic Ovarian Syndrome: a Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  Javad Heshmati; Farnaz Farsi; Somaye Yosaee; Maryam Razavi; Mahroo Rezaeinejad; Elham Karimie; Mahdi Sepidarkish
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

Review 9.  Associations between TNF-α and interleukin gene polymorphisms with polycystic ovary syndrome risk: a systematic review and meta-analysis.

Authors:  Haijing Wu; Ke Yu; Zhenghui Yang
Journal:  J Assist Reprod Genet       Date:  2015-02-18       Impact factor: 3.412

Review 10.  Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan.

Authors:  H Teede; A Deeks; L Moran
Journal:  BMC Med       Date:  2010-06-30       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.